1 Harvard Medical School , Boston, Massachusetts.
2 Department of Surgery-Urology, Brigham and Women's Hospital , Boston, Massachusetts.
J Womens Health (Larchmt). 2018 Apr;27(4):444-457. doi: 10.1089/jwh.2016.6196. Epub 2017 Oct 27.
As a leading cause of morbidity and mortality in the United States and worldwide, obesity is a disease that is frequently encountered in clinical practice today and requires a range of medical interventions. While obesity affects both men and women across all ages, multiple issues are particularly germane to women's health, particularly as obesity is more prevalent among women than men in the United States and obesity among women of reproductive health relates to the growing issue of childhood obesity. Discussed herein are the epidemiology and pathophysiology of obesity along with the impact of perinatal obesity on fetal programming. Guidance on screening and management of obesity through lifestyle intervention, pharmacologic therapy, and bariatric surgery, as well as avoidance of weight-promoting medications wherever possible, is elaborated. Particular attention is paid to the contribution of these modalities to weight loss as well as their impact on obesity-related comorbidities that affect a woman's overall health, such as type 2 diabetes and hypertension, and her reproductive and gynecologic health. With modest weight loss, women with obesity can achieve notable improvements in chronic medical conditions, fertility, pregnancy outcomes, and symptoms of pelvic floor disorders. Moreover, as children born to women after bariatric surgery-induced weight loss show improved metabolic outcomes, this demonstrates a role for maternal weight loss in reducing risk of development of metabolic disturbances in children. In light of the immense cost burden and mortality from obesity, it is important to emphasize the role of lifestyle intervention, pharmacologic management, and bariatric surgery for weight loss in clinical practice to mitigate the impact of obesity on women's health.
肥胖是美国和全球发病率和死亡率的主要原因之一,也是当今临床实践中经常遇到的一种疾病,需要多种医疗干预措施。虽然肥胖影响所有年龄段的男性和女性,但有多个问题与女性健康特别相关,尤其是在美国,肥胖在女性中比男性更为普遍,而肥胖的育龄妇女与儿童肥胖日益严重的问题有关。本文讨论了肥胖的流行病学和病理生理学,以及围产期肥胖对胎儿编程的影响。详细阐述了通过生活方式干预、药物治疗和减重手术来筛查和管理肥胖的指导,以及尽可能避免促进体重增加的药物。特别关注这些方法对体重减轻的贡献,以及它们对影响女性整体健康的肥胖相关合并症的影响,如 2 型糖尿病和高血压,以及她的生殖和妇科健康。肥胖妇女只要适度减轻体重,就能显著改善慢性疾病、生育能力、妊娠结局和盆底疾病症状。此外,由于接受减重手术后的女性所生的孩子代谢结果得到改善,这表明母亲减轻体重在降低儿童代谢紊乱风险方面发挥了作用。鉴于肥胖带来的巨大经济负担和死亡率,强调在临床实践中通过生活方式干预、药物管理和减重手术来减轻体重对女性健康的影响非常重要。